Cure for Alzheimer's Disease: Cost or Value?
This article was originally published in RPM Report
Executive Summary
If the societal reaction to the costs to cure Hep C is any indicator, a potential cure for Alzheimer’s will surely stir controversy assuming breakthrough-level pricing. A financing solution may be the only way to reward developers for the value of the therapy and address the challenges facing insurers.